Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$4.14 – $15.95
100% from low
Exchange
OTC Link
OS
GENFIT ORD
No one on the platform currently holds GNFTF.
No tracked institution reports a position in GNFTF as of their last filing.
No one on the platform has traded GNFTF yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $94M | +11.3% | $0.38 | $0.23–$0.56 | 42.0× | 1 |
| 2027 | $104M | +10.3% | $0.82 | $0.49–$1.21 | 19.4× | 1 |
| 2028 | $142M | +36.0% | $1.07 | $0.64–$1.58 | 14.8× | 1 |
| 2029 | $171M | +20.7% | $2.76 | $1.65–$4.06 | 5.8× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 3 of the last 7 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-04-02 | $-0.04 | $-0.04 | +0.0% |
| 2025-09-22 | $1.21 | $-0.24 | -119.5% |
| 2025-04-24 | $-0.24 | $-0.58 | -138.3% |
| 2024-09-19 | $0.33 | $0.50 | +51.2% |
| 2024-04-04 | $1.35 | $-0.16 | -112.0% |
| 2023-09-20 | $-0.39 | $-0.42 | -7.6% |
| 2023-04-13 | $-1.08 | $-0.27 | +75.2% |
| $84M |
| — |
| MLLCFMolecular Partners AG | $3.80 | +0.00% | $143M | — |
| NDTPNDT Pharmaceuticals Inc. | $0.55 | +0.00% | $88M | — |
Source: Financial Modeling Prep · peers by sector/industry